197 related articles for article (PubMed ID: 32241263)
1. Somatic synonymous mutations in regulatory elements contribute to the genetic aetiology of melanoma.
Zhang D; Xia J
BMC Med Genomics; 2020 Apr; 13(Suppl 5):43. PubMed ID: 32241263
[TBL] [Abstract][Full Text] [Related]
2. The functional relevance of somatic synonymous mutations in melanoma and other cancers.
Gotea V; Gartner JJ; Qutob N; Elnitski L; Samuels Y
Pigment Cell Melanoma Res; 2015 Nov; 28(6):673-84. PubMed ID: 26300548
[TBL] [Abstract][Full Text] [Related]
3. The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations.
Diederichs S; Bartsch L; Berkmann JC; Fröse K; Heitmann J; Hoppe C; Iggena D; Jazmati D; Karschnia P; Linsenmeier M; Maulhardt T; Möhrmann L; Morstein J; Paffenholz SV; Röpenack P; Rückert T; Sandig L; Schell M; Steinmann A; Voss G; Wasmuth J; Weinberger ME; Wullenkord R
EMBO Mol Med; 2016 May; 8(5):442-57. PubMed ID: 26992833
[TBL] [Abstract][Full Text] [Related]
4. Functional annotation of noncoding mutations in cancer.
Umer HM; Smolinska K; Komorowski J; Wadelius C
Life Sci Alliance; 2021 Sep; 4(9):. PubMed ID: 34282050
[TBL] [Abstract][Full Text] [Related]
5. Cis-regulatory somatic mutations and gene-expression alteration in B-cell lymphomas.
Mathelier A; Lefebvre C; Zhang AW; Arenillas DJ; Ding J; Wasserman WW; Shah SP
Genome Biol; 2015 Apr; 16(1):84. PubMed ID: 25903198
[TBL] [Abstract][Full Text] [Related]
6. Systematic Screening of Promoter Regions Pinpoints Functional Cis-Regulatory Mutations in a Cutaneous Melanoma Genome.
Poulos RC; Thoms JA; Shah A; Beck D; Pimanda JE; Wong JW
Mol Cancer Res; 2015 Aug; 13(8):1218-26. PubMed ID: 26082173
[TBL] [Abstract][Full Text] [Related]
7. Synonymous mutations that regulate translation speed might play a non-negligible role in liver cancer development.
Li Q; Li J; Yu CP; Chang S; Xie LL; Wang S
BMC Cancer; 2021 Apr; 21(1):388. PubMed ID: 33836673
[TBL] [Abstract][Full Text] [Related]
8. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
[TBL] [Abstract][Full Text] [Related]
9. The search for cis-regulatory driver mutations in cancer genomes.
Poulos RC; Sloane MA; Hesson LB; Wong JW
Oncotarget; 2015 Oct; 6(32):32509-25. PubMed ID: 26356674
[TBL] [Abstract][Full Text] [Related]
10. Analysis of SDHD promoter mutations in various types of melanoma.
Scholz SL; Horn S; Murali R; Möller I; Sucker A; Sondermann W; Stiller M; Schilling B; Livingstone E; Zimmer L; Reis H; Metz CH; Zeschnigk M; Paschen A; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
Oncotarget; 2015 Sep; 6(28):25868-82. PubMed ID: 26327518
[TBL] [Abstract][Full Text] [Related]
11. Synonymous mutations frequently act as driver mutations in human cancers.
Supek F; Miñana B; Valcárcel J; Gabaldón T; Lehner B
Cell; 2014 Mar; 156(6):1324-1335. PubMed ID: 24630730
[TBL] [Abstract][Full Text] [Related]
12. De Novo Synonymous Mutations in Regulatory Elements Contribute to the Genetic Etiology of Autism and Schizophrenia.
Takata A; Ionita-Laza I; Gogos JA; Xu B; Karayiorgou M
Neuron; 2016 Mar; 89(5):940-7. PubMed ID: 26938441
[TBL] [Abstract][Full Text] [Related]
13. Identification of High-Impact cis-Regulatory Mutations Using Transcription Factor Specific Random Forest Models.
Svetlichnyy D; Imrichova H; Fiers M; Kalender Atak Z; Aerts S
PLoS Comput Biol; 2015 Nov; 11(11):e1004590. PubMed ID: 26562774
[TBL] [Abstract][Full Text] [Related]
14. Nonsynonymous, synonymous and nonsense mutations in human cancer-related genes undergo stronger purifying selections than expectation.
Chu D; Wei L
BMC Cancer; 2019 Apr; 19(1):359. PubMed ID: 30991970
[TBL] [Abstract][Full Text] [Related]
15. Transcription Factors Involved in Tumorigenesis Are Over-Represented in Mutated Active DNA-Binding Sites in Neuroblastoma.
Capasso M; Lasorsa VA; Cimmino F; Avitabile M; Cantalupo S; Montella A; De Angelis B; Morini M; de Torres C; Castellano A; Locatelli F; Iolascon A
Cancer Res; 2020 Feb; 80(3):382-393. PubMed ID: 31784426
[TBL] [Abstract][Full Text] [Related]
16. Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma.
Gartner JJ; Parker SC; Prickett TD; Dutton-Regester K; Stitzel ML; Lin JC; Davis S; Simhadri VL; Jha S; Katagiri N; Gotea V; Teer JK; Wei X; Morken MA; Bhanot UK; ; Chen G; Elnitski LL; Davies MA; Gershenwald JE; Carter H; Karchin R; Robinson W; Robinson S; Rosenberg SA; Collins FS; Parmigiani G; Komar AA; Kimchi-Sarfaty C; Hayward NK; Margulies EH; Samuels Y
Proc Natl Acad Sci U S A; 2013 Aug; 110(33):13481-6. PubMed ID: 23901115
[TBL] [Abstract][Full Text] [Related]
17. Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma.
Wan Q; Sang X; Jin L; Wang Z
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32098099
[TBL] [Abstract][Full Text] [Related]
18. Depletion of somatic mutations in splicing-associated sequences in cancer genomes.
Hurst LD; Batada NN
Genome Biol; 2017 Nov; 18(1):213. PubMed ID: 29115978
[TBL] [Abstract][Full Text] [Related]
19. Identification of Potential Biomarkers for Anti-PD-1 Therapy in Melanoma by Weighted Correlation Network Analysis.
Wang X; Chai Z; Li Y; Long F; Hao Y; Pan G; Liu M; Li B
Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32316408
[TBL] [Abstract][Full Text] [Related]
20. Adjusting for background mutation frequency biases improves the identification of cancer driver genes.
Evans P; Avey S; Kong Y; Krauthammer M
IEEE Trans Nanobioscience; 2013 Sep; 12(3):150-7. PubMed ID: 23694700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
